PAUL W MAFFUID Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL W MAFFUID.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL W MAFFUID. PAUL W MAFFUID is VP, Pharmaceutical Development in ARENA PHARMACEUTICALS INC ($ARNA) and EXECUTIVE VICE PRESIDENT in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Vice President in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX).
Latest Insider Trading Transactions of PAUL W MAFFUID
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | A | 2.04 | 195,000 | 397,800 | 195,000 | |
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | A | 2.04 | 195,000 | 397,800 | 195,000 | |
| Jan 18 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 0.92 | 38,054 | 35,010 | 283,703 | 321.8 K to 283.7 K (-11.83 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | M | 0.00 | 406,382 | 0 | 0 | |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 0.96 | 10,207 | 9,799 | 321,757 | 332 K to 321.8 K (-3.07 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 0.98 | 35,166 | 34,463 | 331,964 | 367.1 K to 332 K (-9.58 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 0.96 | 60,478 | 58,059 | 367,130 | 427.6 K to 367.1 K (-14.14 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Buy | M | 0.00 | 406,382 | 0 | 427,608 | 21.2 K to 427.6 K (+1,914.55 %) |
| Oct 04 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | A | 0.00 | 307,999 | 0 | 307,999 | |
| Sep 18 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | A | 0.00 | 98,383 | 0 | 98,383 | |
| Aug 02 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | S | 6.29 | 2,079 | 13,077 | 0 | |
| Aug 02 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | S | 5.55 | 2,079 | 11,538 | 0 | |
| Aug 02 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Buy | P | 0.00 | 3,228 | 0 | 27,311 | 24.1 K to 27.3 K (+13.40 %) |
| Aug 02 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Buy | P | 1.75 | 2,857 | 5,000 | 24,083 | 21.2 K to 24.1 K (+13.46 %) |
| Apr 14 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.00 | 1,369 | 2,738 | 21,226 | 22.6 K to 21.2 K (-6.06 %) |
| Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.00 | 200 | 400 | 22,595 | 22.8 K to 22.6 K (-0.88 %) |
| Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.00 | 400 | 800 | 22,795 | 23.2 K to 22.8 K (-1.72 %) |
| Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.01 | 450 | 902 | 23,195 | 23.6 K to 23.2 K (-1.90 %) |
| Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.15 | 867 | 1,862 | 23,645 | 24.5 K to 23.6 K (-3.54 %) |
| Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.15 | 1,800 | 3,872 | 24,512 | 26.3 K to 24.5 K (-6.84 %) |
| Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Sell | S | 2.25 | 1,000 | 2,250 | 26,312 | 27.3 K to 26.3 K (-3.66 %) |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | M | 0.00 | 15,045 | 0 | 15,046 | |
| Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Buy | M | 0.00 | 15,045 | 0 | 27,312 | 12.3 K to 27.3 K (+122.65 %) |
| Feb 08 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | A | 2.99 | 100,000 | 299,000 | 100,000 | |
| Jan 03 2017 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | A | 3.38 | 20,100 | 67,938 | 20,100 | |
| Aug 30 2016 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | A | 5.00 | 20,100 | 100,500 | 20,100 | |
| Aug 19 2016 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | P | 6.29 | 2,079 | 13,077 | 2,079 | |
| Aug 19 2016 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | P | 5.55 | 2,079 | 11,538 | 2,079 | |
| Aug 19 2016 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Buy | P | 0.00 | 2,079 | 0 | 12,267 | 10.2 K to 12.3 K (+20.41 %) |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | M | 0.00 | 111,334 | 0 | 222,666 | |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Payment of Exercise | F | 0.00 | 40,944 | 0 | 75,390 | 116.3 K to 75.4 K (-35.20 %) |
| Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Buy | M | 0.00 | 111,334 | 0 | 116,334 | 5 K to 116.3 K (+2,226.68 %) |
| Feb 18 2016 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | VICE PRESIDENT | Option Exercise | A | 0.49 | 60,000 | 29,400 | 60,000 | |
| Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | Vice President | Option Exercise | A | 0.00 | 334,000 | 0 | 334,000 | |
| Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | Vice President | Option Exercise | A | 2.30 | 334,000 | 768,200 | 334,000 | |
| Jul 02 2004 | ARNA | ARENA PHARMACEUTIC ... | MAFFUID PAUL W | VP, Pharmaceutical ... | Buy | J | 4.64 | 108 | 501 | 16,496 | 16.4 K to 16.5 K (+0.66 %) |
| Apr 02 2004 | ARNA | ARENA PHARMACEUTIC ... | MAFFUID PAUL W | VP, Pharmaceutical ... | Buy | J | 5.10 | 194 | 989 | 16,388 | 16.2 K to 16.4 K (+1.20 %) |
Page: 1